Oculis Holding AG SEC filings OCSAW
Oculis Holding AG has 138 filings in SEC EDGAR's recent list, going back to Nov 7, 2022. Its latest annual report, Form 20-F, was filed on Mar 4, 2026 for the period ended Dec 31, 2025. The most recent current report (Form 6-K) was filed on Nov 3, 2026. The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Apr 29, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Mar 27, 2026 | — |
| 144 | Notice of proposed sale | Mar 9, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Nov 14, 2025 | — |
| 144 | Notice of proposed sale | Oct 9, 2025 | — |
| 144 | Notice of proposed sale | Sep 23, 2025 | — |
| 144 | Notice of proposed sale | Mar 14, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 12, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 11, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Jan 3, 2025 | — |
| SC 13G | Ownership over 5% (passive) | Dec 9, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 7, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 13, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 12, 2024 | — |
| SC 13G | Ownership over 5% (passive) | Feb 9, 2024 | — |
| SC 13G | Ownership over 5% (passive) | May 4, 2023 | — |
| SC 13G | Ownership over 5% (passive) | May 2, 2023 | — |
| SC 13G | Ownership over 5% (passive) | Mar 15, 2023 | — |
| SC 13G | Ownership over 5% (passive) | Mar 13, 2023 | — |
Showing 19 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- OCS (Nasdaq), OCSAW (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- Switzerland
- Headquarters
- Zug, Switzerland
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1953530
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.